Loading...
Loading...
Reverse cellular aging with precision sound waves
This therapy is still emerging. Gabriel can help you understand the evidence and identify legitimate research or waitlist pathways.

During the visit
Comprehensive biological age assessment (epigenetic clocks, telomere testing, senescence markers)
Customized ultrasound protocol based on target areas and senescence burden
Non-invasive ultrasound applicator placed on treatment areas
30-minute session with pulsed waves (1.5s on/off duty cycle at 32.2 kHz)
Duration
30 minutes per session, protocols vary by treatment area
Starting at
$500
Practitioner access
Research-only
Category
Longevity / Regenerative
About this treatment
Low-Frequency Ultrasound (LFU) Rejuvenation is a breakthrough therapy that uses precisely calibrated ultrasound waves at 32.2 kHz to reverse cellular senescence, the process where aged cells stop dividing but refuse to die, accumulating in tissues and poisoning their neighbors with inflammatory signals. These 'zombie cells' are now recognized as a primary driver of aging, responsible for tissue degradation, chronic inflammation, organ decline, and age-related disease.
What makes LFU revolutionary is that it doesn't destroy senescent cells (senolysis). It rejuvenates them. Published research from the University of Texas Health Science Center demonstrates that 30-minute ultrasound sessions with a specific duty cycle (1.5 seconds on, 1.5 seconds off) reverse 15 distinct characteristics of cellular senescence. Over 30% of previously non-dividing cells resume normal growth within 4-5 days. Telomere length is restored. Inflammatory markers normalize. Mitochondrial function rebounds.
In animal studies, mice receiving LFU throughout their lives showed lifespan gains comparable to the best senolytic drugs, but without the side effects of killing cells. Even more remarkable: normal cells treated with LFU begin secreting growth-stimulating factors that partially restore nearby senescent cells, creating a rejuvenation cascade. Unlike rapamycin (which only slows new senescence), LFU reverses existing senescence. This is not anti-aging. This is age reversal.
Visit flow
Comprehensive biological age assessment (epigenetic clocks, telomere testing, senescence markers)
Customized ultrasound protocol based on target areas and senescence burden
Non-invasive ultrasound applicator placed on treatment areas
30-minute session with pulsed waves (1.5s on/off duty cycle at 32.2 kHz)
Sessions are painless, most feel gentle warmth or subtle vibration
Recommended protocol: multiple sessions over weeks, maintenance sessions monthly
Post-treatment biomarker tracking to measure senescence reduction
Can be combined with other longevity interventions (NAD+, peptides, fasting protocols)
Best for
Anyone serious about biological age reversal, not just slowing aging
Those with elevated senescence burden (chronic inflammation, accelerated aging)
Longevity-focused individuals seeking cutting-edge interventions
People who want alternatives to senolytic drugs (dasatinib + quercetin, fisetin)
Key outcomes
Reverses 15 characteristics of cellular senescence (published research)
30%+ of senescent cells resume normal division within 4-5 days
Restores telomere length in treated cells
Normalizes senescence markers (p16, p21, p53, beta-galactosidase)
Gabriel intelligence
Treatment fit
Root-cause context before you book
Gabriel can help decide whether low-frequency ultrasound rejuvenation fits your symptoms, labs, and recovery goals before you spend money on a session.
Protocol pairing
Connect sessions to a real plan
Gabriel can pair this with diagnostics, supplements, peptides, and follow-up cadence so it fits into a real protocol instead of sitting in isolation.
Practitioner match
Find the right clinic, not just the nearest one
Gabriel uses trust, treatment fit, and modality overlap to surface practitioners who are more likely to be a strong match for this exact treatment path.
Evidence & safety
Preclinical evidence is strong and published in peer-reviewed journals. UTHSCSA research demonstrates clear reversal of senescence markers in vitro and in vivo (mouse models). Patent filed (US20240001155A1). Human clinical trials are the next step. The ultrasound parameters used are within established safety ranges for medical ultrasound. This is frontier research: extremely promising with rigorous published data, but not yet validated in large-scale human trials. Early adopters should work with qualified longevity physicians.
Related treatments
Use these when you want adjacent options in the same category before deciding what to book.
Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.